|
Title
|
|
|
|
Phase
|
|
|
|
Protocol IDs
|
|
|
|
Hepatic Arterial Infusion With Melphalan Compared With Standard Therapy in Treating Patients With Unresectable Liver Metastases Due to Melanoma
|
|
|
|
Phase III
|
|
|
|
NCI-06-C-0088
NCI-P6701, NCT00324727
|
|
|
Vaccine Therapy and Autologous Lymphocyte Infusion With or Without Fludarabine in Treating Patients With Metastatic Melanoma
|
|
|
|
Phase II, Phase I
|
|
|
|
MCC-13649
LAC-USC-10M-05-2, 6241, NCI-6241, LAC-USC-HS-05-00068, NCT00313508
|
|
|
Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma
|
|
|
|
Phase II
|
|
|
|
MCC-15241
MDX-010-16, NCI-6446, 6446, NCT00084656, LAC-USC-10M036
|
|
|
Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer
|
|
|
|
Phase II
|
|
|
|
NCI-04-C-0273
NCI-6332, DELCATH-G990039, NCT00096083
|
|
|
Vorinostat in Treating Patients With Metastatic or Unresectable Melanoma
|
|
|
|
Phase II
|
|
|
|
PMH-PHL-040
NCI-6916, 6916, NCT00121225
|
|
|
AZD2171 in Treating Patients With Recurrent or Stage IV Melanoma
|
|
|
|
Phase II
|
|
|
|
PMH-PHL-038
7137, NCT00243061
|
|
|
Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
|
|
|
|
Phase II
|
|
|
|
MSKCC-05122
NCT00445965
|
|
|
VEGF Trap in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
|
|
|
|
Phase II
|
|
|
|
CCC-PHII-77
7522, NCT00450255
|
|
|
Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma
|
|
|
|
Phase II
|
|
|
|
POHA-0604
06-04, NCT00489944
|
|
|
Study of Ipilimumab to Treat Melanoma in Patients With Brain Metastases
|
|
|
|
Phase II
|
|
|
|
CA184-042
NCT00623766
|
|